Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DEGS1 | O15121 | 1/20 | 0.79 |
| ▸ | POLB | P06746 | 3/20 | 0.78 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.78 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.74 |
| ▸ | NPC1 | O15118 | 5/20 | 0.71 |
| ▸ | RAB9A | P51151 | 5/20 | 0.71 |
| ▸ | MEN1 | O00255 | 2/20 | 0.71 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.71 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.71 |
| ▸ | MAPT | P10636 | 1/20 | 0.69 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.69 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.67 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.67 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.66 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.66 |
| ▸ | NQO2 | P16083 | 1/20 | 0.66 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.65 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.65 |
| ▸ | PGR | P06401 | 1/20 | 0.65 |
| ▸ | MAOA | P21397 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11688443 | 0.98 | DEGS1 (0.83) | DEGS1POLBKDM4EPTPN1NPC1 | |
| SCHEMBL7112688 | 0.93 | DEGS1 (0.93) | DEGS1POLBKDM4EPTPN1NPC1 | |
| N-Phenylbenzamide SCHEMBL27671345 | 0.92 | POLB (0.71) | DEGS1POLBKDM4EPTPN1NPC1 | |
| SCHEMBL1603641 | 0.92 | DEGS1 (0.79) | DEGS1POLBKDM4EPTPN1NPC1 | |
| SCHEMBL126415 | 0.91 | PTPN1 (0.87) | POLBKDM4EPTPN1NPC1RAB9A | |
| SCHEMBL8420639 | 0.89 | DEGS1 (0.75) | DEGS1POLBKDM4EPTPN1NPC1 | |
| SCHEMBL899585 | 0.89 | DEGS1 (0.75) | DEGS1POLBKDM4EPTPN1NPC1 | |
| SCHEMBL900928 | 0.89 | DEGS1 (0.75) | DEGS1POLBKDM4EPTPN1NPC1 | |
| SCHEMBL14715824 | 0.89 | NPC1 (0.88) | POLBKDM4EPTPN1NPC1RAB9A | |
| SCHEMBL18103163 | 0.89 | NPC1 (0.88) | POLBKDM4EPTPN1NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 265 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210332001-A1 | SYNTHESIS AND ANTI-TUMOR ACTIVITIES OF ACYL-PARA-AMINOPHENOL DERIVATIVES | MONTEFIORE MEDICAL CENTER | 2021-10-28 | — | — | US | claimed |
| CN-102702013-B | Nuclear receptor binding agents | GTX INC. (US) | 2016-02-10 | — | — | CN | claimed |
| US-9161542-B2 | Pesticidal compositions and related methods | DOW AGROSCIENCES LLC (US) | 2015-10-20 | — | — | US | claimed |
| WO-2012162595-A2 | PESTICIDAL COMPOSITIONS AND RELATED METHODS | DOW AGROSCIENCES LLC (US) | 2012-11-29 | — | — | WO | claimed |
| US-20120302611-A1 | PESTICIDAL COMPOSITIONS AND RELATED METHODS | DOW AGROSCIENCES LLC (US) | 2012-11-29 | — | — | US | claimed |
| US-8187788-B2 | Photosensitive resin composition and photosensitive film | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2012-05-29 | — | — | US | claimed |
| US-20090191385-A1 | Photosensitive Resin Composition and Photosensitive Film | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2009-07-30 | — | — | US | claimed |
| CN-101336227-A | Nuclear receptor binding agents | GTX INC (US) | 2008-12-31 | — | — | CN | claimed |
| CN-1633290-A | Mono-and bicyclic pyrrole derivatives inhibiting ligand interaction with higher glycation end product receptors | TRANSTECH PHARMA INC (US) | 2005-06-29 | — | — | CN | claimed |
| EP-0409313-A2 | Poly carbonates endowed with high-fluidity characteristics and process for preparing them | ENICHEM S.p.A. (IT) | 1991-01-23 | — | — | EP | claimed |
| US-4517005-A | Aminophenol urease inhibitors and urease inhibited urea based fertilizer compositions | ALLIED CORPORATION (US) | 1985-05-14 | — | — | US | claimed |
| US-3968140-A | PROSTAGLANDINS | THE UPJOHN COMPANY (US) | 1976-07-06 | — | — | US | claimed |
| US-3952048-A | PROSTAGLANDINS | THE UPJOHN COMPANY (US) | 1976-04-20 | — | — | US | claimed |
| US-3931281-A | PROSTAGLANDINS | THE UPJOHN COMPANY (US) | 1976-01-06 | — | — | US | claimed |
| WO-2025063899-A1 | A DYNAMIC CROSSLINKER, COVALENT ADAPTABLE NETWORK COMPRISING POLYMER NETWORK CROSSLINKED BY SAID DYNAMIC CROSSLINKER AND RELATED METHODS THEREOF | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2025-03-27 | — | — | WO | disclosed |
| CN-116217911-B | Wear-resistant polycarbonate | 万华化学集团股份有限公司 | 2025-01-10 | — | — | CN | disclosed |
| CN-119080631-A | Method for preparing N-aryl amide compound by catalyzing nitrite-mediated selenium | 浙江工业大学 | 2024-12-06 | — | — | CN | disclosed |
| US-3932486-A | GASTRIC SECRETION INHIBITORS, ANTISPASMODIC, ANTIASTHMATIC, HYPOTENSIVE | THE UPJOHN COMPANY (US) | 1976-01-13 | — | — | US | disclosed |
| US-3931281-A | PROSTAGLANDINS | THE UPJOHN COMPANY (US) | 1976-01-06 | — | — | US | disclosed |
| US-3931285-A | PROSTAGLANDINS | THE UPJOHN COMPANY (US) | 1976-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120302611-A1 | PESTICIDAL COMPOSITIONS AND RELATED METHODS | PRDX6, PRDX2, PRDX1 | DEGS1 793/4885POLB 4219/4885KDM4E 777/4885 |
| US-20210332001-A1 | SYNTHESIS AND ANTI-TUMOR ACTIVITIES OF ACYL-PARA-AMINOPHENOL DERIVATIVES | AADAC, FABP7, NPEPPS | DEGS1 3593/4885POLB 1743/4885KDM4E 592/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.